News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Noznesky Justin J
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/03/2023 |
4
| Noznesky Justin J (Chief Mktg & Strategy Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 547 shares
@ $38.11, valued at
$20.8k
|
|
01/03/2023 |
4
| Noznesky Justin J (Chief Mktg & Strategy Officer) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 585 shares
@ $34.86, valued at
$20.4k
|
|
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2020 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Gifted 250 shares
@ $0 |
|
04/20/2020 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 10,000 shares
@ $40, valued at
$400k
|
|
04/09/2020 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 10,000 shares
@ $35, valued at
$350k
|
|
03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2020 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 15,000 shares
@ $32.89, valued at
$493.4k
Sold 14,134 shares
@ $32.89, valued at
$464.9k
Exercised 15,000 options to buy
@ $18.3, valued at
$274.5k
|
|
08/16/2019 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Gifted 2,500 shares
@ $0 |
|
06/19/2019 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 10,000 shares
@ $30, valued at
$300k
|
|
05/02/2019 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 15,000 shares
@ $30, valued at
$450k
Exercised 15,000 options to buy
@ $18.3, valued at
$274.5k
|
|
04/16/2019 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 12,569 shares
@ $27.64, valued at
$347.4k
|
|
03/06/2019 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 10,562 shares
@ $0 Paid exercise price by delivering 18,845 shares
@ $30.77, valued at
$579.9k
|
|
08/17/2018 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 4,000 shares
@ $30.32, valued at
$121.3k
|
|
06/01/2018 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Gifted 3,000 shares
@ $0 |
|
05/17/2018 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 4,000 shares
@ $23.05, valued at
$92.2k
|
|
03/05/2018 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Granted 25,726 shares
@ $0 Paid exercise price by delivering 14,803 shares
@ $17.71, valued at
$262.2k
|
|
02/16/2018 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Sold 4,000 shares
@ $17.03, valued at
$68.1k
|
|
01/09/2018 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Paid exercise price by delivering 3,182 shares
@ $17.99, valued at
$57.2k
|
|
08/03/2017 |
4
| Noznesky Justin J (SVP, Mktg & Business Develop) has filed a Form 4 on AtriCure, Inc.
Txns:
| Gifted 3,000 shares
@ $0 |
|
03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|